Dr. Michael Dudley’s Full Interview on COVID-19

Dr. Michael Dudley is the president & CEO of Qpex, a bio-tech company in southern California. With over 30 years of experience in anti-infective research and development, he has a wealth of knowledge about infectious diseases, part of which stems from his experience being on the team that treated the first AIDS patient in America.

UPDATE: On May 15, 2020 Dr. Dudley rejoined Charles Morris on Haven Today to give a timely update on where we are today with the Coronavirus Pandemic. The full interview could not fit on Friday’s program, so we’re posting the full 25-minute conversation here.

Back in March as the pandemic began escalating in North America, Dr. Dudley originally joined Charles Morris to talk about COVID-19, how viruses like this function, what we can expect in the future, and how we can ultimately put our hope in Christ. Only about half of the interview could fit in Monday’s program, so we’re posting the whole 30-minute conversation here.

For more on the Coronavirus Pandemic and how you can be encouraged to respond with a posture of faith, not fear, check out this post by Charles Morris offering “Biblical Hope to Overcome Fear.”

3 Comments

  • Kathleen LaRoche says:

    Appreciate Haven Today and Charles Morris having Dr. Dudley sharing his insight and knowledge on Covid-19. Thank you for this program.

  • Jan Martens says:

    I’m Overwhelmed Beyond Words. When I heard Charles Morris On my fone. Asking for 🙏 Prayer request. To take the TIME 🕰️ To CALL📲📱☎️ people. How The L❤️VE SHINES For JESUS CHRIST ✝️.In Such Care And Compassion In The Name Of JESUS 💖. All For The GLORY Of GOD☀️☀️☀️WOW
    I will send a prayer 🙏✝️In a bit. I’m still So Overwhelmed With Your L❤️VE Through JESUS And Such Wonderful Way “During Such A Time As This”🤴 In The Book Of The BIBLE~Queen Esther. 😷 🌎🗺️ ❤️

  • MARLEY BECKER says:

    Thanks to Haven for this interview. Good to hear truth and not all the scary info floating around.

Leave a Reply

Your email address will not be published. Required fields are marked *